Wyden Seeks Info on Questionable Medicare Marketing Activity (1)

A rising number of complaints have prompted Senate Finance Committee Chairman Ron Wyden to seek information about “potentially deceptive” marketing tactics of Medicare prescription drug plans and private Medicare managed care plans.

In letters sent recently to 15 state insurance commissioners, Wyden (D-Ore.) said he is “concerned about the increase in beneficiary complaints” regarding marketing materials from Medicare “Part D” drug plans and Medicare Advantage plans. The Committee on Finance provides Senate oversight of both programs.

As of May 2022, the Centers for Medicare & Medicaid Services reported that the number of complaints had doubled from 2020 to 2021, Wyden’s ...